Cryopak Industries Inc.

Cryopak Industries Inc.

October 25, 2005 09:00 ET

Cryopak Announces New Pharmaceutical Packaging Program with GlaxoSmithKline in Canada

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Oct. 25, 2005) - Cryopak Industries Inc. (TSX VENTURE:CYK) today announced that it would be providing GlaxoSmithKline Inc. (GSK) with insulated containers and internal thermal components for shipping of its temperature sensitive vaccines in Canada. This new program has begun and will be rolled out across Canada by the end of the year.

"We are pleased today to be announcing our affiliation with yet another leader in the pharmaceutical industry. I think it speaks volumes about the reputation we have developed in the industry for delivering quality products and services to our customers, and that we can continue to secure new business relationships of this magnitude," stated Martin Carsky, President and CEO of Cryopak.

About Cryopak

With ISO 9001:2000 certified facilities in Vancouver and Montreal, we are a leading provider of temperature-controlling products and solutions serving global pharmaceutical companies, as well as fine North American retailers and consumer goods companies. In our pharmaceutical business we engineer solutions and supply products that help our customers safely transport their temperature sensitive vaccines. In our retail business, we develop, manufacture and sell reusable ice substitutes, flexible hot and cold compresses, reusable gel ice and instant hot and cold packs. These products are marketed under such popular brand names as Ice-Pak™, Flexible Ice™ Blanket, Simply Cozy®, and Flex Pak™. We also manufacture these same products under private label for many well-known consumer goods companies. Our shares are listed on the TSX Venture Exchange under the symbol CYK.

Contact Information

  • Cryopak Industries Inc.
    Martin Carsky
    President and CEO